Browsing Centre for Preventative Neurology by Author "Ingram, G"
Now showing items 1-3 of 3
-
Real-world persistence of multiple sclerosis disease-modifying therapies.
Tallantyre, EC; Dobson, R; Froud, JLJ; St John, FA; Anderson, VM; Arun, T; Buckley, L; Evangelou, N; Ford, HL; Galea, I (John Wiley & Sons Ltd, 2024-04-03)BACKGROUND AND PURPOSE: Treatment persistence is the continuation of therapy over time. It reflects a combination of treatment efficacy and tolerability. We aimed to describe real-world rates of persistence on disease-modifying ... -
Response to COVID-19 booster vaccinations in seronegative people with multiple sclerosis
Tallantyre, EC; Scurr, MJ; Vickaryous, N; Richards, A; Anderson, V; Baker, D; Chance, R; Evangelou, N; George, K; Giovannoni, G (2022) -
Risk of COVID-19 in people with multiple sclerosis who are seronegative following vaccination
Zaloum, SA; Wood, CH; Tank, P; Upcott, M; Vickaryous, N; Anderson, V; Baker, D; Chance, R; Evangelou, N; George, K (2023)